HJ Science Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Income	-135.08	-202.32
Depreciation & Amortization	2.74	2.96
Loss (Gain) From Sale of Assets	-0	-
Loss (Gain) From Sale of Investments	-6.54	-5.65
Loss (Gain) on Equity Investments	0.16	0.24
Stock-Based Compensation	25.05	-
Other Operating Activities	0.13	123.73
Change in Accounts Payable	28.63	11.65
Change in Unearned Revenue	5.89	-1.8
Change in Other Net Operating Assets	-10.4	-6.85
Operating Cash Flow	-89.43	-78.04
Operating Cash Flow Growth	-	-
Capital Expenditures	-1.51	-1.63
Sale of Property, Plant & Equipment	0	-
Investment in Securities	-36.56	-46.4
Other Investing Activities	-	1.04
Investing Cash Flow	-38.07	-46.98
Short-Term Debt Issued	10	-
Total Debt Issued	10	-
Long-Term Debt Repaid	-0.39	-0.66
Net Debt Issued (Repaid)	9.61	-0.66
Issuance of Common Stock	70	0.61
Other Financing Activities	-2.2	-0.05
Financing Cash Flow	77.41	-0.11
Net Cash Flow	-50.09	-125.13
Free Cash Flow	-90.95	-79.67
Free Cash Flow Growth	-	-
Free Cash Flow Margin	-695.85%	-3095.26%
Free Cash Flow Per Share	-1.53	-2.02
Levered Free Cash Flow	-30.14	-
Unlevered Free Cash Flow	-30.06	-
Cash Interest Paid	0.12	0.05
Change in Working Capital	24.11	3